News Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer Continue Reading Previous Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive OfficerNext EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023 Related Stories News Senteon and Compliance Scorecard Announce Strategic Partnership to Simplify Continuous Compliance News VelocityEHS Expands Safe Can’t Wait Initiative with the Launch of “Rewiring Risk,” a New Podcast Featuring Executive Conversations on the Future of Workplace Safety News Infoblox Completes Kentik Acquisition to Bring Together Authoritative DNS, Asset Visibility and Real-Time Network Intelligence News Cequence Security Announces Deployment at NTT DOCOMO News A New Trick for an Old Dog: Slinky Dog Finds New Life as an Antenna News Pointr and VergeSense Partner to Combine AI Mapping with Predictive Planning for the Future of the Hybrid Workplace